Maurizio Mascarin Selected Research

Burkitt Lymphoma (Burkitt's Lymphoma)

1/2021

MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Mascarin Research Topics

Disease

20	Hodgkin Disease (Hodgkin's Disease) 12/2023 - 01/2016
12	Neoplasms (Cancer) 10/2023 - 04/2004
5	Medulloblastoma 08/2022 - 03/2010
3	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 06/2021
3	Infections 02/2023 - 02/2022
3	COVID-19 02/2023 - 07/2020
3	Ependymoma 12/2022 - 07/2011
2	Lymphoma (Lymphomas) 03/2022 - 01/2013
2	Necrosis 01/2022 - 06/2021
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 11/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2013
2	Neoplasm Metastasis (Metastasis) 06/2021 - 04/2004
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 01/2013
2	Primitive Neuroectodermal Tumors (PNET) 05/2014 - 03/2010
2	Familial ependymoma 08/2006 - 04/2004
1	Cardiotoxicity 10/2023
1	Hand-Foot Syndrome 10/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2021
1	Sclerosis 05/2021
1	Left Ventricular Dysfunction 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Wilms Tumor (Wilm's Tumor) 12/2019
1	Rhabdomyosarcoma 12/2019
1	Inflammation (Inflammations) 01/2018
1	Central Nervous System Neoplasms 01/2018
1	Pathologic Complete Response 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Nasopharyngeal Carcinoma 09/2011
1	Residual Neoplasm 07/2011

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2018
3	Ifosfamide FDA LinkGeneric 10/2023 - 11/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 11/2014
2	Brentuximab VedotinIBA 01/2023 - 10/2022
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2013
2	Cell-Free Nucleic AcidsIBA 01/2016 - 01/2013
2	Temozolomide (Temodar)FDA LinkGeneric 05/2014 - 03/2010
1	OsteopontinIBA 12/2023
1	1-dodecylpyridoxal (PLD)IBA 10/2023
1	liposomal doxorubicin (Doxil)FDA Link 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 10/2023
1	Bendamustine Hydrochloride FDA Link 01/2023
1	NivolumabIBA 01/2023
1	COVID-19 VaccinesIBA 02/2022
1	VaccinesIBA 02/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	mifamurtideIBA 01/2022
1	Rituximab (Mabthera)FDA Link 11/2021
1	Melphalan (Alkeran)FDA LinkGeneric 06/2021
1	Busulfan (Busulfex)FDA Link 06/2021
1	AnthracyclinesIBA 01/2021
1	Janus KinasesIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	LigandsIBA 10/2019
1	Fluorine-18IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2017
1	HLA-G Antigens (HLA G)IBA 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2014
1	Methotrexate (Mexate)FDA LinkGeneric 11/2014
1	Cytidine Diphosphate (CDP)IBA 11/2014
1	Anaplastic Lymphoma KinaseIBA 01/2013

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 08/2022 - 04/2004
12	Radiotherapy 01/2023 - 04/2004
8	Therapeutics 02/2023 - 12/2019
5	Salvage Therapy 12/2022 - 08/2006
2	Neoadjuvant Therapy 06/2021 - 09/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2011 - 03/2010
1	Music Therapy 02/2023
1	Cell Transplantation 01/2023
1	Adjuvant Radiotherapy 08/2022
1	Adjuvant Chemotherapy 08/2022
1	Contraindications 02/2022
1	Treatment Delay 02/2022
1	Stem Cell Transplantation 06/2021
1	Phototherapy (Light Therapy) 01/2020
1	Ligation 10/2019
1	Combined Modality Therapy 01/2015
1	Induction Chemotherapy 09/2011
1	Craniospinal Irradiation 03/2010